Spots Global Cancer Trial Database for De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma
Official Title: De-escalation of Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Study ID: NCT04158518
Conditions
Study Description
Brief Summary: The purpose of this study is to explore the efficacy and safety of image guided de-escalation protocols in patients with locoregionally advanced nasopharyngeal carcinoma (NPC). So the investigators studied whether toxicities reducing treatment with omitted concurrent chemotherapy after good response to induction chemotherapy would maintain survival outcomes while improving tolerability for patients with locoregionally advanced nasopharyngeal carcinoma.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Fudan Universtiy Shanghai Cancer Centre, Shanghai, , China
Contact Details
Name: Chaosu Hu, MD
Affiliation: Fudan University Shanghai Cancer Centre
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
